Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT00973206

Factors Influencing Cardiovascular Prognosis

Factors Influencing Cardiovascular Prognosis in Hypertensive Patients (Pythia Study)

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to identify risks for cardiovascular events in a follow up period of 10 years.

Detailed description

Inclusion criteria * Age \> 50 years volunteers (2 towns of 15000 residents one in the north and one in the south of Greece) * End points * 5-10 years cardiovascular morbidity and mortality Measurements at baseline * Anthropometrics * Age (M\>55 years; W\>65 years) * Weight-height- BMI * Abdominal obesity (Waist circumference\>102 cm(M), \>88cm (W) Family history * Family history of premature CV disease (M at age\<55 years; W at age\<65 years) History * Smoking * Diabetes Mellitus, * Established Heart disease: myocardial infarction; angina; coronary revascularization; heart failure * Established renal disease \[diabetic nephropathy; renal impairment (serum creatinine M\>133, W\>124 mmol/l); proteinuria (\> 300 mg/24 h)\] * Cerebrovascular disease: ischaemic stroke; cerebral haemorrhage; transient ischaemic attack * Peripheral artery disease * Advanced retinopathy: haemorrhages or exudates, papilloedema * Treatment Measurements * Measurements Blood pressure * Clinic BP * 24h ABPM * Home BP Heart * Electrocardiographic LVH * Echocardiographic LVH Vessels * Carotid wall thickening or plaque * Carotid-femoral pulse wave velocity * Ankle/brachial BP index Lipids or other risk factors * Total cholesterol, Tg, HDL, LDL * Plasma creatinine, estimated glomerular filtration rate * Fasting plasma glucose or postload plasma glucose * Microalbuminuria and albumin-creatinine ratio * Glucose tolerance test * Follow up each 3 year with all the above measurements

Conditions

Timeline

Start date
2017-01-01
Primary completion
2027-01-01
Completion
2027-01-01
First posted
2009-09-09
Last updated
2014-06-25

Source: ClinicalTrials.gov record NCT00973206. Inclusion in this directory is not an endorsement.